The Valley Desk

NCT07900633 · Interventional trial

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk

Overall registry status Not yet recruiting

Phase 3

Conditions Cardiovascular Diseases, Diabetes Mellitus, Type 2, Obesity, Overweight

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov